HSCA Comments on FDA Bulk Substance Guidance
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments on the U.S. Food and Drug Administration (FDA) draft guidance on the use of bulk substances under Section 503B of the Federal Food, Drug, and Cosmetic Act. HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs), the sourcing and purchasing partners to virtually all of America’s 7,000+ hospitals.
Lear MoreHSCA Comments on DEA Proposed Rule on Opioid Production Limits
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments on the U.S. Drug Enforcement Administration (DEA) proposed rule on annual opioid production limits.
HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs), the sourcing and purchasing partners to virtually all of America’s 7,000+ hospitals, as well as the vast majority of the 68,000+ long-term care facilities, surgery centers, clinics, and other healthcare providers.
Lear MoreHSCA Announces Healthcare Cybersecurity Key Considerations
The Healthcare Supply Chain Association (HSCA) today announced the release of key cybersecurity considerations for healthcare providers, medical device manufacturers and service providers to help protect patient health, safety and privacy. In conjunction with the release of the key considerations, HSCA also published ‘Recommendations for Medical Device Cybersecurity Terms and Conditions,’ which details potential purchasing contract terms and conditions that could help ensure rapid adoption of rigorous cybersecurity measures.
Lear MoreHSCA Urges DEA to Take Steps to Mitigate Shortages of Injectable Opioids
Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph., today released the following statement encouraging the Drug Enforcement Administration (DEA) to take critical steps to ease current shortages of injectable opioids:
“Hospitals and other healthcare providers are currently experiencing critical shortages of a number of injectable opioid medications – including morphine, hydromorphone, and fentanyl – that are an essential element of treatment for post – surgical and medical pain management. Without the necessary opioids available, many medical procedures would have to be postponed or cancelled, jeopardizing the wellbeing of patients across the country. Controlling narcotics use – particularly outpatient prescription opioid abuse – remains a public health priority that HSCA supports.”
Lear More